Protalix BioTherapeutics (PLX) Other Non Operating Income (2010 - 2026)
Protalix BioTherapeutics (PLX) recorded quarterly Other Non Operating Income of $188000.0 in Q1 2026, down 29.06% quarter-over-quarter from $265000.0 in Q4 2025, and down 55.13% on a YoY basis from $419000.0 in Q1 2025.
Protalix BioTherapeutics (PLX) Other Non Operating Income (2010 - 2026) Analysis & Trends
Protalix BioTherapeutics' Other Non Operating Income history runs 17 years deep, the most recent figure standing at $188000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 55.13% year-over-year to $188000.0; the TTM figure through Mar 2026 stood at $1.0 million (up 145.87% YoY), while the FY2025 annual figure was $1.1 million, up 114.03% from the prior year.
- Other Non Operating Income was $188000.0 for Q1 2026 at Protalix BioTherapeutics, down from $265000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.8 million in Q4 2022 to a low of -$680000.0 in Q4 2024.
- Historically, Other Non Operating Income has averaged $365411.8 across 5 years, with a median of $272000.0 in 2025.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income jumped 88500.0% in 2022, then sank 1737.84% in 2024.
- A 5-year view of Other Non Operating Income shows it stood at $1.8 million in 2022, then slumped by 102.09% to -$37000.0 in 2023, then tumbled by 1737.84% to -$680000.0 in 2024, then surged by 138.97% to $265000.0 in 2025, then dropped by 29.06% to $188000.0 in 2026.
- The last three Other Non Operating Income figures came in at $188000.0 (Q1 2026), $265000.0 (Q4 2025), and $288000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Protalix BioTherapeutics | 176.47 Mn | 165.67 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 188,000.00 |
| Dec 31, 2025 | 265,000.00 |
| Sep 30, 2025 | 288,000.00 |
| Jun 30, 2025 | 272,000.00 |
| Mar 31, 2025 | 419,000.00 |
| Dec 31, 2024 | -680,000.00 |
| Sep 30, 2024 | 151,000.00 |
| Jun 30, 2024 | 522,000.00 |
| Mar 31, 2024 | 513,000.00 |
| Dec 31, 2023 | -37,000.00 |
| Sep 30, 2023 | 628,000.00 |
| Jun 30, 2023 | 531,000.00 |
| Mar 31, 2023 | 172,000.00 |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 197,000.00 |
| Jun 30, 2022 | 813,000.00 |
| Mar 31, 2022 | 202,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | 96,000.00 |
| Jun 30, 2021 | 128,000.00 |